Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias
Cardiac Arrhythmia, Supraventricular Arrhythmia
About this trial
This is an interventional treatment trial for Cardiac Arrhythmia focused on measuring Electrophysiological study, Atropine, Isoprenaline, Supraventricular arrhythmia, Ablation
Eligibility Criteria
Inclusion Criteria: Patients with indication for electrophysiological study according to present guidelines of European Society of Cardiology Exclusion Criteria: Not willing or incapable to give written informed consent. Previous diagnosed ventricle tachycardia or fibrillation Previous diagnosed atrial fibrillation or flutter Glaucoma (contraindication for atropine)
Sites / Locations
- Department of Electrocardiology Medical University of Lodz
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Atropine
Isoprenaline
Patients in whom during electrophysiological study atropine will be used. I.v. bolus of 0.01 mg/kg b.w. will be administered to reach the increase of heart rate of 25% or up to 130/min. If necessary, dose will be increased every 5 minutes until mention above parameters are achieved. Maximum dose will be 0.4 mg/kg b.w.
Patients in whom during electrophysiological study isoprenaline will be used. Continuous i.v. infusion of 0.01 mcg/kg b.w./min will be administered to reach the increase of heart rate of 25% or up to 130/min. If necessary, dose will be doubled every 5 minutes until mention above parameters are achieved. Maximum dose will be 20 mcg/min.